{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:22:18Z","timestamp":1779250938090,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the clinical efficacy of haploidentical haematopoietic stem cell transplantation (haplo-HSCT) for the treatment of malignant infantile osteopetrosis (MIOP) and intermediate osteopetrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Children with MIOP and IOP who underwent haplo-HSCT in Beijing Children\u2019s Hospital, Capital Medical University, from January 2010 to May 2018 were retrospectively analysed. Data relating to the clinical manifestations, engraftment, and prognosis of the children were extracted from medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-seven patients, including 18 males and 9 females, with an onset age of 12 (0.04\u201372)\u00a0months were enrolled in this study. The median time from diagnosis to transplantation was 4 (1\u201323)\u00a0months. All patients received haplo-HSCT with a myeloablative conditioning regimen (including fludarabine, busulfan, and cyclophosphamide). Graft versus host disease (GVHD) prophylaxis was based on anti-human T lymphocyte porcine immunoglobulin\/anti-human thymus globulin, methotrexate, and mycophenolate mofetil. The median observation time was 55.2 (0.3\u2013126.2) months. By the end of follow-up, twenty patients survived and seven patients died. The 5\u00a0year overall survival rate was 73.9%. Stage I-II acute GVHD was observed in 20 patients, stage III GVHD in 1 patient and no patients had stage IV disease. Chronic GVHD was observed in 11 patients (40.7%) and was controlled by anti-GVHD therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Haplo-HSCT was an effective treatment for MIOP and IOP, with a high survival rate and significantly improved clinical symptoms. For patients with a vision impairment before HSCT, the improvement was slow after transplantation. The incidence of GVHD was high but mild and was effectively controlled by appropriate treatment. These data indicated that haplo-HSCT was a feasible treatment for MIOP and IOP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-021-01955-6","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T07:02:58Z","timestamp":1626332578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Haploidentical haematopoietic stem cell transplantation for malignant infantile osteopetrosis and intermediate osteopetrosis: a retrospective analysis of a single centre"],"prefix":"10.1186","volume":"16","author":[{"given":"Guanghua","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenguang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9946-8567","authenticated-orcid":false,"given":"Tianyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huyong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoquan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"issue":"27","key":"1955_CR1","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1056\/NEJMra040952","volume":"351","author":"J Tolar","year":"2004","unstructured":"Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351(27):2839\u201349. https:\/\/doi.org\/10.1056\/NEJMra040952.","journal-title":"N Engl J Med"},{"key":"1955_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejmg.2007.01.005","volume":"50","author":"N Souraty","year":"2007","unstructured":"Souraty N, Noun P, Djambas-Khayat C, et al. Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis. Eur J Med Genet. 2007;50:188\u201399. https:\/\/doi.org\/10.1016\/j.ejmg.2007.01.005.","journal-title":"Eur J Med Genet"},{"key":"1955_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/ejhg.2008.234","volume":"17","author":"EA Bliznetz","year":"2009","unstructured":"Bliznetz EA, Tverskaya SM, Zinchenko RA, et al. Genetic analysis of autosomal recessive osteopetrosis in Chuvashiya: the unique splice site mutation in TCIRG1 gene spread by the founder effect. Eur J Hum Genet. 2009;17:664\u201372. https:\/\/doi.org\/10.1038\/ejhg.2008.234.","journal-title":"Eur J Hum Genet"},{"key":"1955_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0022-3476(77)80441-1","volume":"91","author":"R Lor\u00eda-Cort\u00e9s","year":"1977","unstructured":"Lor\u00eda-Cort\u00e9s R, Quesada-Calvo E, Cordero-Chaverri C. Osteopetrosis in children: a report of 26 cases. J Pediatr. 1977;91:43\u20137. https:\/\/doi.org\/10.1016\/s0022-3476(77)80441-1.","journal-title":"J Pediatr"},{"key":"1955_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.bmt.1704194","volume":"32","author":"GJ Driessen","year":"2003","unstructured":"Driessen GJ, Gerritsen EJ, Fischer A, et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant. 2003;32:657\u201363. https:\/\/doi.org\/10.1038\/sj.bmt.1704194.","journal-title":"Bone Marrow Transplant"},{"key":"1955_CR6","unstructured":"Sobacchi C, Villa A, Schulz A, et al. CLCN7-Related Osteopetrosis. Adam MP, Ardinger HH, Pagon RA, et al. eds. Gene reviews. Seattle (WA): University of Washington, Seattle, 2007:1"},{"issue":"9","key":"1955_CR7","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1210\/jc.2017-01127","volume":"102","author":"CC Wu","year":"2017","unstructured":"Wu CC, Econs MJ, DiMeglio LA, et al. Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group. J Clin Endocrinol Metab. 2017;102(9):3111\u201323. https:\/\/doi.org\/10.1210\/jc.2017-01127.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1955_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD International Consortium. Biol Blood Marrow Transplant. 2016;22(1):4\u201310. https:\/\/doi.org\/10.1016\/j.bbmt.2015.09.001.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1955_CR9","doi-asserted-by":"publisher","unstructured":"Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21(3):389\u2013401.e1. https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001.","DOI":"10.1016\/j.bbmt.2014.12.001"},{"issue":"2","key":"1955_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/ejh.13536","volume":"106","author":"J Torres Canizales","year":"2021","unstructured":"Torres Canizales J, Ferreras C, Pascual A, et al. Haploidentical transplantation in pediatric non-malignant diseases: a retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH). Eur J Haematol. 2021;106(2):196\u2013204. https:\/\/doi.org\/10.1111\/ejh.13536.","journal-title":"Eur J Haematol"},{"issue":"8","key":"1955_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90(8):918\u201326. https:\/\/doi.org\/10.1097\/TP.0b013e3181f24e8d.","journal-title":"Transplantation"},{"issue":"6","key":"1955_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44(6):778\u201383. https:\/\/doi.org\/10.1097\/00007890-198712000-00011.","journal-title":"Transplantation"},{"issue":"4","key":"1955_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.24953\/turkjped.2017.04.012","volume":"59","author":"M Tfifha","year":"2017","unstructured":"Tfifha M, Gaha M, Gamaoun W, et al. Clinical and imaging features of malignant infantile osteopetrosis. Turk J Pediatr. 2017;59(4):452\u20137. https:\/\/doi.org\/10.24953\/turkjped.2017.04.012.","journal-title":"Turk J Pediatr"},{"issue":"6","key":"1955_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1182\/bloodadvances.2018025890","volume":"3","author":"P Stepensky","year":"2019","unstructured":"Stepensky P, Grisariu S, Avni B, et al. Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years. Blood Adv. 2019;3(6):862\u20138. https:\/\/doi.org\/10.1182\/bloodadvances.2018025890.","journal-title":"Blood Adv"},{"issue":"4","key":"1955_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ejpn.2018.04.005","volume":"22","author":"RS Badv","year":"2018","unstructured":"Badv RS, Dehghani SS, Behfar M, et al. Impact of hematopoietic stem cell transplant on VEP and ABR values of the patients with malignant infantile osteopetrosis. Eur J Paediatr Neurol. 2018;22(4):718\u201324. https:\/\/doi.org\/10.1016\/j.ejpn.2018.04.005.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"1955_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/pbc.25801","volume":"63","author":"J Natsheh","year":"2016","unstructured":"Natsheh J, Drozdinsky G, Simanovsky N, et al. Improved outcomes of hematopoietic stem cell transplantation in patients with infantile malignant osteopetrosis using fludarabine-based conditioning. Pediatr Blood Cancer. 2016;63(3):535\u201340. https:\/\/doi.org\/10.1002\/pbc.25801.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1955_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood-2015-01-625541","volume":"126","author":"PJ Orchard","year":"2015","unstructured":"Orchard PJ, Fasth AL, Le Rademacher J, et al. Hematopoietic stem cell transplantation for infantile osteopetrosis. Blood. 2015;126(2):270\u20136. https:\/\/doi.org\/10.1182\/blood-2015-01-625541.","journal-title":"Blood"},{"issue":"11","key":"1955_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/bmt.2016.180","volume":"51","author":"TL Bahr","year":"2016","unstructured":"Bahr TL, Lund T, Sando NM, et al. Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children. Bone Marrow Transplant. 2016;51(11):1546\u20138. https:\/\/doi.org\/10.1038\/bmt.2016.180.","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"1955_CR19","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.bbmt.2016.07.015","volume":"22","author":"R Chiesa","year":"2016","unstructured":"Chiesa R, Ruggeri A, Paviglianiti A, et al. Outcomes after unrelated umbilical cord blood transplantation for children with osteopetrosis. Biol Blood Marrow Transplant. 2016;22(11):1997\u20132002. https:\/\/doi.org\/10.1016\/j.bbmt.2016.07.015.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"1955_CR20","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/cncr.27761","volume":"119","author":"Y Wang","year":"2013","unstructured":"Wang Y, Liu DH, Liu KY, et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer. 2013;119(5):978\u201385. https:\/\/doi.org\/10.1002\/cncr.27761.","journal-title":"Cancer"},{"issue":"2","key":"1955_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.bmt.1702743","volume":"27","author":"J Kapelushnik","year":"2001","unstructured":"Kapelushnik J, Shalev C, Yaniv I, et al. Osteopetrosis: a single centre experience of stem cell transplantation and prenatal diagnosis. Bone Marrow Transplant. 2001;27(2):129\u201332. https:\/\/doi.org\/10.1038\/sj.bmt.1702743.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"1955_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2007.08.029","volume":"42","author":"A Del Fattore","year":"2008","unstructured":"Del Fattore A, Cappariello A, Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone. 2008;42(1):19\u201329. https:\/\/doi.org\/10.1016\/j.bone.2007.08.029.","journal-title":"Bone"},{"key":"1955_CR23","unstructured":"Carreras E, Bertz H, Arcese W, et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood. 1998;92(10):3599\u2013604."},{"issue":"6","key":"1955_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27010","volume":"65","author":"B Shadur","year":"2018","unstructured":"Shadur B, Zaidman I, NaserEddin A, et al. Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning. Pediatr Blood Cancer. 2018;65(6): e27010. https:\/\/doi.org\/10.1002\/pbc.27010.","journal-title":"Pediatr Blood Cancer"},{"key":"1955_CR25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1359\/jbmr.060403","volume":"21","author":"A Pangrazion","year":"2006","unstructured":"Pangrazion A, Poliani PL, Megarbane A, et al. Mutations in OSTM1(grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neutral involvement. J Bone Miner Res. 2006;21:1098\u2013105. https:\/\/doi.org\/10.1359\/jbmr.060403.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1955_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pcl.2009.11.006","volume":"57","author":"CG Steward","year":"2010","unstructured":"Steward CG. Hematopoietic stem cell transplantation for osteopetrosis. Pediatr Clin North Am. 2010;57(1):171\u201380. https:\/\/doi.org\/10.1016\/j.pcl.2009.11.006.","journal-title":"Pediatr Clin North Am"},{"key":"1955_CR27","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1359\/JBMR.050807","volume":"20","author":"BM Nichholls","year":"2005","unstructured":"Nichholls BM, Bredius RG, Handy NA, et al. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor. J Bone Miner Res. 2005;20:2264\u201370. https:\/\/doi.org\/10.1359\/JBMR.050807.","journal-title":"J Bone Miner Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01955-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T07:13:36Z","timestamp":1626333216000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01955-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1955"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01955-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-195831\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"31 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of Beijing Children\u2019s Hospital, Capital Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript. All parents signed informed consent forms and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}